THA Clinical Trial - Influence of Spinal Deformity on THA

Clinical Trial Description

Investigators will Find out if there is change in the acetabular cup including the abduction and anteversion angles in patients who had THA and has spinal deformity ;

Study Design

See also
Status	Clinical Trial	Phase
Completed	`NCT03691337` - Fascia Iliaca Blocks for Total Hip Arthroplasty	Phase 4
Completed	`NCT06019026` - Five-year Migration Pattern and Bone Mineral Density for the Tri-Lock and Summit Femoral Stems.	N/A
Completed	`NCT01831401` - A Study Investigating the Effect of Patient Pelvic Positioning and Method of Acetabular Component Insertion on Acetabular Component Inclination During Total Hip Arthroplasty (THA)	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT03691337 - Fascia Iliaca Blocks for Total Hip Arthroplasty

Phase 4

Completed

NCT06019026 - Five-year Migration Pattern and Bone Mineral Density for the Tri-Lock and Summit Femoral Stems.

N/A

Completed

NCT01831401 - A Study Investigating the Effect of Patient Pelvic Positioning and Method of Acetabular Component Insertion on Acetabular Component Inclination During Total Hip Arthroplasty (THA)

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05892523
Study type	Observational
Source	Assiut University
Contact	Amr A Mazhar, physician
Phone	01013612542
Email	amrmazhar96@gmail.com
Status	Not yet recruiting
Phase
Start date	November 8, 2023
Completion date	January 1, 2025

Influence of Spinal Deformity on THA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms